[Pharma industry reinvents itself in the turmoil. Part 2. Opportunities]

In the first article we described how pharmaceutical industry is facing major challenges in general. In this second part, we intend to focus on new concepts and developments, which might sound «futuristic» for most of us. However, this seems definitely «work in rapid progress», especially concerning, for example, the use of the pharmacogenome (prerequisite for treatment personalization), «clever» medication, 3D printing and labelling with QR code. The future is bright but we cannot omit to quote the ever growing role of incumbent actors, both in the fields of medication production as well as distribution.